COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ), possibility of reaching target blood pressure (BP) le...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
Médium: Artigo
Jazyk:Inglês
Vydáno: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Edice:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Témata:
metoprolol tartrate
metoprolol succinate
arterial hypertension
antihypertensive therapy
On-line přístup:https://www.rpcardio.com/jour/article/view/367
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky